Last viewed:
RMD
Prices are updated after-hours
RMD
|
$178.395
0.44%
410K
|
Health Technology
(0.0% 1d)
(-9.6% 1m)
(-22.7% 1y)
(0.0% 2d)
(0.0% 3d)
(-6.1% 7d)
(629.6%
volume)
Earnings Calendar: 2024-01-24
Market Cap: $ 26,239,922,175
http://www.resmed.com
Sec
Filling
|
Patents
| 7770 employees
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment engages in the supply of business management software as a service to out-of-hospital health providers. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
respiratory
diagnostics
msa
add to watch list
Paper trade
email alert is off
Press-releases
Sleep apnea implants market size to grow by USD 282.4 Million from 2022 to 2027, Technavio
Published: 2024-04-09
(Crawled : 05:00)
- prnewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -7.78%
| O: 0.27%
H: 2.84%
C: 2.79%
million
market
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
Published: 2024-04-04
(Crawled : 20:00)
- globenewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -6.04%
| O: 0.01%
H: 2.45%
C: 2.02%
report
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published: 2024-04-02
(Crawled : 20:00)
- globenewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -5.71%
| O: 0.88%
H: 1.64%
C: 0.03%
LUNG
|
$7.49
-0.13%
91K
|
Health Technology
| -12.69%
| O: 0.59%
H: 1.64%
C: -7.13%
GILD
|
News
|
$66.33
0.26%
2.8M
|
Health Technology
| -7.2%
| O: -0.12%
H: 0.24%
C: -1.54%
financial
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
Published: 2024-03-15
(Crawled : 07:00)
- globenewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -9.35%
| O: -1.52%
H: 0.83%
C: 0.64%
world
global
Global Respiratory Care Devices Research Report 2024: A $38.75+ Billion Market by 2030, Driven by Rising Demand in Home Care Settings, Rising Incidence of Allergies, and Sleep Apnea Epidemic
Published: 2024-03-12
(Crawled : 00:00)
- prnewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -8.39%
| O: -0.26%
H: 2.88%
C: 2.39%
MDT
|
$79.255
0.08%
2.6M
|
Health Technology
| -7.51%
| O: -0.41%
H: 1.1%
C: 0.69%
GE
|
$149.17
-2.47%
6.2M
|
Electronic Technology
| -6.54%
| O: 0.53%
H: 0.21%
C: 0.01%
MASI
|
$134.69
-0.91%
120K
|
Health Technology
| 5.67%
| O: -0.48%
H: 0.88%
C: 0.31%
report
respiratory
care
research
global
home
market
Digital Therapeutics Market size will grow at a CAGR of 25.59% between 2022 and 2027, The increasing prevalence of chronic diseases boosts market growth
Published: 2024-03-08
(Crawled : 05:00)
- prnewswire.com
BTTX
|
$0.009
180K
|
| -94.8%
| O: 0.73%
H: 13.64%
C: 11.05%
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -9.75%
| O: -0.31%
H: 1.45%
C: -1.85%
MDT
|
$79.255
0.08%
2.6M
|
Health Technology
| -7.13%
| O: 0.39%
H: 0.92%
C: -0.41%
DRIO
|
$1.16
0.87%
19K
|
Health Technology
| -31.98%
| O: -1.16%
H: 5.88%
C: 2.94%
GOOGL
|
News
S
|
$154.29
-1.1%
16M
|
Technology Services
| 15.58%
| O: -0.13%
H: 2.89%
C: 0.89%
GOOG
|
News
S
|
$155.48
-1.26%
11M
|
Technology Services
| 16.02%
| O: -0.15%
H: 2.93%
C: 0.93%
therapeutics
growth
market
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
Published: 2024-03-06
(Crawled : 14:00)
- globenewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -2.14%
| O: 0.76%
H: 3.0%
C: 2.96%
comfort
mask
ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications
Published: 2024-02-15
(Crawled : 21:00)
- globenewswire.com
SLRN
|
$4.815
-1.33%
1.3M
|
| -33.33%
| O: -0.53%
H: 13.48%
C: 11.48%
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -4.81%
| O: -0.54%
H: 1.24%
C: -0.64%
INGN
|
$6.8
-4.09%
160K
|
Health Technology
| -31.53%
| O: -2.27%
H: 3.53%
C: 1.11%
communications
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
Published: 2024-02-12
(Crawled : 21:00)
- globenewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| -4.76%
| O: -1.57%
H: 1.1%
C: -0.27%
positive
therapy
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
Published: 2024-01-24
(Crawled : 21:00)
- globenewswire.com
RMD
|
$178.395
0.44%
410K
|
Health Technology
| 1.19%
| O: 10.35%
H: 0.25%
C: -1.69%
year
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001127602-24-008924
4
2024-03-07
2024-03-04
Sell
S
81
6607